JO
ZIVO

John Overdeck’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

John Overdeck’s Portfolio ZIVO Stock Details ZIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,228
Closed -$143K – 5056
2021
Q3 		$143K Buy
+5,228
New +$114K ﹤0.01% 4034

Other funds holding ZIVO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.9B AUM 36.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

John Overdeck's ZIVO Position: Q4 2021 in Review

John Overdeck sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2021, closing a stake of 5,228 shares — an estimated $143K sold.

John Overdeck first reported a position in ZIVO in Q3 2021 and held it in 1 quarter. The position peaked at $143K in Q3 2021. 12 funds tracked by Wall St. Rank hold ZIVO as of Q4 2021.

  • John Overdeck reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • John Overdeck sold 5,228 Zivo Bioscience, Inc. Common Stock shares in Q4 2021, an estimated $143K.
  • John Overdeck first reported a position in Zivo Bioscience, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • John Overdeck's Zivo Bioscience, Inc. Common Stock position peaked at $143K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2021.

Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.